Literature DB >> 18310748

Surgical site infection with methicillin-resistant Staphylococcus aureus after primary total hip replacement.

R J Walls1, S J Roche, A O'Rourke, J P McCabe.   

Abstract

We have analysed the management and clinical outcome of a series of consecutive patients who had a total hip replacement and developed post-operative surgical site infection (SSI) with methicillin-resistant Staphylococcus aureus. The incidence of this infection was 1% over a period of five years. We studied SSI in 15 patients (16 infections) with a mean age of 72.7 years (53 to 81). In all, 12 of the infections occurred early and half of the infections involved the prosthesis, resulting in an increase of 11-fold in the cumulative hospital stay. Methicillin-resistant Staph. aureus was successfully eradicated in all the patients after a mean follow-up of 53.6 months (25 to 88). Superficial incisional infections resolved after antibiotic therapy alone while deep infections required multiple operative debridements. Attempted retention of the implant in early organ space infections was successful in only one of five patients. Only three patients with implant-level infections obtained a pain-free, functional prosthesis while a further three required excision arthroplasty. We have formulated a protocol of treatment which may serve as a guide in the management of these infections.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18310748     DOI: 10.1302/0301-620X.90B3.20155

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  20 in total

1.  Mouse model of chronic post-arthroplasty infection: noninvasive in vivo bioluminescence imaging to monitor bacterial burden for long-term study.

Authors:  Jonathan R Pribaz; Nicholas M Bernthal; Fabrizio Billi; John S Cho; Romela Irene Ramos; Yi Guo; Ambrose L Cheung; Kevin P Francis; Lloyd S Miller
Journal:  J Orthop Res       Date:  2011-08-11       Impact factor: 3.494

2.  The effectiveness of methicillin-resistant Staphylococcus aureus colonisation screening in asymptomatic healthcare workers in an Irish orthopaedic unit.

Authors:  S P Edmundson; K M Hirpara; D Bennett
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-02-12       Impact factor: 3.267

3.  Retention treatment after periprosthetic total hip arthroplasty infection.

Authors:  Ho-Rim Choi; Fabian von Knoch; Abdurrahman O Kandil; David Zurakowski; Slade Moore; Henrik Malchau
Journal:  Int Orthop       Date:  2011-07-27       Impact factor: 3.075

4.  [Periprosthetic infections following total hip replacement with ESBL-forming bacteria: importance for clinical practice].

Authors:  M Haenle; A Podbielski; M Ellenrieder; R Skripitz; K Arndt; W Mittelmeier; R Bader; H Gollwitzer
Journal:  Orthopade       Date:  2011-06       Impact factor: 1.087

Review 5.  Virulence Factor Targeting of the Bacterial Pathogen Staphylococcus aureus for Vaccine and Therapeutics.

Authors:  Trevor L Kane; Katelyn E Carothers; Shaun W Lee
Journal:  Curr Drug Targets       Date:  2018       Impact factor: 3.465

6.  Arginase-1 Expression in Myeloid Cells Regulates Staphylococcus aureus Planktonic but Not Biofilm Infection.

Authors:  Kelsey J Yamada; Cortney E Heim; Amy L Aldrich; Casey M Gries; Anna G Staudacher; Tammy Kielian
Journal:  Infect Immun       Date:  2018-06-21       Impact factor: 3.441

7.  Evaluation of an interdisciplinary therapy algorithm in patients with prosthetic joint infections.

Authors:  Matthias D Wimmer; Thomas M Randau; Sabine Petersdorf; Geert I Pagenstert; Markus Weißkopf; Dieter C Wirtz; Sascha Gravius
Journal:  Int Orthop       Date:  2013-07-13       Impact factor: 3.075

8.  IL-12 promotes myeloid-derived suppressor cell recruitment and bacterial persistence during Staphylococcus aureus orthopedic implant infection.

Authors:  Cortney E Heim; Debbie Vidlak; Tyler D Scherr; Curtis W Hartman; Kevin L Garvin; Tammy Kielian
Journal:  J Immunol       Date:  2015-03-11       Impact factor: 5.422

9.  A mouse model of post-arthroplasty Staphylococcus aureus joint infection to evaluate in vivo the efficacy of antimicrobial implant coatings.

Authors:  Nicholas M Bernthal; Alexandra I Stavrakis; Fabrizio Billi; John S Cho; Thomas J Kremen; Scott I Simon; Ambrose L Cheung; Gerald A Finerman; Jay R Lieberman; John S Adams; Lloyd S Miller
Journal:  PLoS One       Date:  2010-09-07       Impact factor: 3.240

10.  In Vivo Efficacy of a "Smart" Antimicrobial Implant Coating.

Authors:  Alexandra I Stavrakis; Suwei Zhu; Vishal Hegde; Amanda H Loftin; Alyssa G Ashbaugh; Jared A Niska; Lloyd S Miller; Tatiana Segura; Nicholas M Bernthal
Journal:  J Bone Joint Surg Am       Date:  2016-07-20       Impact factor: 5.284

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.